MEK activity controls IL-8 expression in tamoxifen-resistant MCF-7 breast cancer cells

Oncology Reports
Sangmin KimSeok Jin Nam

Abstract

Although tamoxifen reduces disease progression, tamoxifen resistance occurs during the course of estrogen receptor-positive [ER+] breast cancer treatment. In the present study, we investigated the possibility that interleukin-8 (IL-8) is a prognostic marker for tamoxifen resistance and aimed to clarify the regulation of IL-8 expression in tamoxifen-resistant cells. Clinically, IL-8 expression is positively correlated with survival in luminal A type breast cancer patients, but not in luminal B type breast cancer patients. In addition, the levels of IL-8 mRNA and protein expression were significantly increased in tamoxifen-resistant (TamR) cells compared to tamoxifen-sensitive (TamS) cells. To determine the regulatory mechanism of IL-8 expression in TamR cells, we analyzed the activities of signaling molecules. Our results showed that the phosphorylation levels of MEK and Akt were markedly increased in TamR cells, but there was no change in the phosphorylation level of p38 MAPK. On the contrary, we observed that elevated IL-8 mRNA expression was suppressed by a specific MEK1/2 inhibitor, UO126, but not by the specific PI-3K inhibitor LY294002, in TamR cells, whereas, we found that overexpression of constitutively active-MEK (CA-M...Continue Reading

References

Nov 1, 1990·Endocrine Reviews·V C Jordan, C S Murphy
Feb 13, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·K AupperleG Firestein
Sep 7, 2001·Cytokine & Growth Factor Reviews·K Xie
Nov 10, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ina H BenoyLuc Y Dirix
Dec 23, 2004·Endocrine-related Cancer·Alistair Ring, Mitch Dowsett
May 9, 2006·The Journal of Surgical Research·Balraj SinghAnthony Lucci
Jan 31, 2007·Breast Cancer Research : BCR·Carine ChaveyGwendal Lazennec
Sep 26, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·V Craig Jordan, Bert W O'Malley
Nov 5, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·David J J Waugh, Catherine Wilson
Jan 7, 2010·The Journal of Clinical Investigation·Christophe GinestierMax S Wicha
Jul 9, 2010·CA: a Cancer Journal for Clinicians·Ahmedin JemalElizabeth Ward
Oct 8, 2011·Breast Cancer Research : BCR·Achim RodyManfred Kaufmann
Sep 18, 2013·Breast Cancer Research : BCR·Jagdeep K SinghRobert B Clarke
Jul 15, 2015·Oncology Reports·Sangmin KimJeong Eon Lee

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.